Advisory Board and Editors Diabetes & Endocrinology
Ana Maria Jimenez-Cebrian
Dr. Ana Maria Jimenez-Cebrian is a Professor within the Department of Nursing and Podiatry at the University of Malaga.
Her primary research areas focus on Confirmatory Factor Analysis, Anthropometrics, Musculoskeletal, Childhood, Gait and Walking.
Goo Jun
I am currently an assistant professor at the University of Texas Health Science Center at Houston. I work on statistical genetics, computational biology, bioinformatics, and sequence data analysis. With backgrounds in machine learning and data mining, my research is focused on development of computational and statistical methods for analysis of massive data to understand genetics and biology of complex traits. I have been working on the analysis of large-scale next-generation sequencing data, for which I developed statistical models and software pipelines for detecting sample contamination, variant discovery, machine-learning based variant filtering, and genotyping of structural variations. I also work on genetics of diabetes, obesity, and related traits and study of metabolomic and microbiome compositions related to genetics of common and complex traits.
Haseeb A. Khan
Distinguished Professor of Biochemistry at College of Science, King Saud University, Riyadh, Saudi Arabia. Group Leader of Analytical and Molecular Bioscience Research Group and a Chair Professor at Research Chair for Biomedical Applications of Nanomaterials, King Saud University. PhD from Aligarh Muslim University, Aligarh, India and received scientific trainings in USA, UK, Denmark and Finland. Fellow of the Royal College of Pathologists (FRCPath) and the Royal Society of Chemistry (FRSC), UK. Authored more than 300 publications including 2 books and 20 book chapters. Recipient of Microsoft eScience Award. Listed in Top-2% World Ranking of Scientists. Research interests are clinical biochemistry, analytical chemistry, environmental chemistry, nanobiotechnology, molecular conservation, bioinformatics, pharmacology, and toxicology.
Mohammed Kuddus
Dr. Mohammed Kuddus is working as a Professor and Chairman of Biochemistry Department at University of Hail, Saudi Arabia. His main research area includes Molecular biology, Industrial enzymes, Extremophiles and Extremozymes, Microbial biotechnology, Food biotechnology, Waste utilization, Value added products, Bioremediation, Biopolymers and Bioplastics. He has published more than 75 research articles in reputed international journals along with 8 books and 22 book chapters; and presented more than 40 abstracts in national/international conferences/symposia. He has been serving as an Editor / Editorial Board Member and Reviewer of various international reputed journals. He has been awarded Young Scientist Projects from the Department of Science and Technology, India and International Foundation for Science, Sweden.
Julia Kzhyshkowska
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Susanne E la Fleur
Associate Professor at the Academic Medical Center, University of Amsterdam and Visiting Professor at Université Paris Diderot-Paris 7. Our group is working on unravelling the mechanistic link between diet composition and the development of obesity and diabetes as a first step towards better understanding the pathogenesis of Type 2 Diabetes Mellitus, focussing on the role of the brain.
Carmelo La Rosa
Carmelo La Rosa is a Professor of Physical-Chemistry at the University of Catania, Italy. He received a master’s degree in Chemistry and Ph.D. in Physical-Chemistry from the University of Catania (Italy), working on lyotropic liquid crystals. After completing postdoctoral training on thermodynamics and kinetics of protein folding-unfolding at the University of Catania and Leiden University (The Netherland), he joined the department of Chemical Sciences, University of Catania. His current research focuses on the biophysics of amyloidogenic proteins and their interaction with model membranes.
Safarina G Malik
Safarina G. Malik is a Principal Investigator at the Genome Diversity and Disease Division of the Mochtar Riady Institute for Nanotechnology, Tangerang, Banten, Indonesia, since January 2022. From 2011 to 2021 she lead the Lifestyle Diseases Research Group at the Eijkman Institute for Molecular Biology, Jakarta, Indonesia. Her key research topics and expertise include genetic diversity, microbiome, mitochondrial genetics and dysfunction, medical genetics, lifestyle disease association, nutrigenetics-nutrigenomics, population genetics and evolution.
Yoshinori Marunaka
Prof. Marunaka is the President and the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Organization of Science and Technology, Ritsumeikan University; Professor Emeritus, Kyoto Prefectural University of Medicine; Former President, Physiological Society of Japan. Former President, International Society of Cancer Metabolism. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 270 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 47, i10-index 190, Citation 7498
David Meyre
David Meyre completed a PhD in quantitative plant genetics in France. Since 2001, he has been working on the elucidation of the genetic bases of obesity and type 2 diabetes. In 2004, he published the first family-based genome-wide scans for childhood and severe adult obesity. He completed the two first successful positional cloning efforts for childhood and severe adult obesity, which identified the positional candidate genes ENPP1 and PCSK1. In 2007, he contributed to the identification of the major susceptibility gene for polygenic obesity FTO. In 2009, he published the first genome-wide association study of extreme obesity in the French population and identified four novel susceptibility-loci. In 2010, he conducted the first genome-wide association meta-analysis for early-onset extreme obesity in German and French populations. In 2012, he identified the third more common form of monogenic obesity (PCSK1 partial deficiency) and demonstrated an important role of the lipid sensor GPR120 in human obesity. He also discovered the first molecular link between obesity and major depression. In 2013, he discovered a novel gene (SIM1) responsible for a syndromic Mendelian form of childhood obesity. In 2016, he discovered that physical activity can blunt the effect of the obesity predisposing gene FTO in diverse ethnic groups. He also demonstrated that genes can predict the outcomes of different types of bariatric surgery.
David S. Milstone
Assistant Professor of Pathology, Brigham and Women's Hospital and Harvard Medical School.
Daniel J Moore
Dr. Moore completed his undergraduate training at Harvard University where he also studied at the MGH Transplantation Biology Research Center (TBRC). He continued his focus in transplantation immunology and autoimmune disease during studies in the MSTP program at the University of Pennsylvania. He subsequently completed his training in pediatrics and pediatric endocrinology at Vanderbilt University Medical Center. His laboratory focus is on the restoration of immune regulation in individuals with autoimmune disease. He pursues this effort through studies on the cellular and molecular biology of effector and regulatory lymphocytes and their responses to tolerance-inducing immune therapies.